Scripta Insights Builds Health Plan Push With Senior Sales Hires

New updates have been reported about Scripta Insights.

Scripta Insights is expanding its commercial leadership to accelerate growth with health plans and benefits consultants, appointing Mark Davis as Vice President of Health Plans & Strategic Growth and Steve Halleen as Senior Director of Consultant Relations. The moves signal a strategic shift from a predominantly self-insured employer focus toward deeper penetration of the health plan market and tighter alignment with national brokerage and consulting channels.

Davis, a veteran healthcare IT sales executive with extensive payer-market experience, is tasked with integrating Scripta’s AI-driven pharmacy navigation platform into health plan offerings to drive measurable pharmacy spend reductions and improved member value. Halleen, a longtime healthcare consultant and former leader of consultant relations at a major benefits technology firm, will formalize and scale Scripta’s relationships with large consulting firms that influence prescription benefit and pharmacy strategy for employers and plans.

According to CEO Eric Levin, these hires are intended to extend Scripta’s existing traction with self-insured employers to payers and their advisory partners, positioning the company as a differentiated pharmacy optimization solution in a market pressured by high drug costs and plan-efficiency demands. For health plans, Scripta aims to embed its Rx navigation tools into existing benefit designs, offering a potential lever to improve medication access and affordability while containing pharmacy trends.

For consultants and brokers, Halleen’s remit is to ensure Scripta’s outcomes, capabilities and economic value proposition are clearly understood and incorporated into client recommendations, a step that could materially expand the company’s distribution footprint. The appointments underscore Scripta’s growth-stage ambitions as a venture-backed digital health company founded in 2019 by physicians, pharmacists and data scientists, and indicate a go-to-market model increasingly reliant on channel partnerships. While financial terms and performance metrics were not disclosed, the leadership additions suggest a focus on scaling recurring revenue through payer contracts and consultant-led employer deals, with potential upside for investors and stakeholders if adoption broadens across the health plan segment.